Carolina Innovations Seminar
"The Story of Oriel Therapeutics"
Thursday, January 7, 2010
5:30-6:30 p.m.
Sitterson Hall, Room 014
University of North Carolina at Chapel Hill
Dr. Paul Atkins co-founded the UNC spin-out company Oriel Therapeutics in 2002. Dr. Atkins is currently the President and Chief Operating Officer of Oriel, which was based on technology developed for dry powder inhaler devices in the lab of Dr. Anthony Hickey of the UNC School of Pharmacy. Prior to founding Oriel, Atkins spent more than ten years with GlaxoSmithKline where he established the Inhaled Product Development group and was responsible for a number of global technical development programs, including the development of HFA metered dose inhalers and novel dry powder inhalers. Oriel Therapeutics is now actively developing a portfolio of respiratory products targeted primarily at asthma and COPD. Dr. Atkins will share the journey of Oriel and their progression from the academic lab to the initiation of clinical trials.
For more information about the OTD seminars, go to:
http://research.unc.edu/otd/carolina_innovations_seminar.php
